Back to search
FDAFDA · Food and drugs·Recall number D-0445-2024

Sterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human injection), Insulin Lispro Injection u-100, 10 mL, Use ONLY with Insulins listed on carton, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285. NDC: 0002-0800-01

Published April 24, 2024 · Recall initiated: March 12, 2024

Summary

FDA records drug Class II recall D-0445-2024, published April 24, 2024 and initiated March 12, 2024. Recalling firm: Eli Lilly & Company; Status: Completed; Reported quantity: 700 vials; Lot: Batch number: D608951C, exp 4/10/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · E-Mail

Get an email if HUMALOG has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
HUMALOG
Manufacturer
Eli Lilly & Company
Distributor
Nationwide USA
Lot
Batch number: D608951C, exp 4/10/2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Sterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human injection), Insulin Lispro Injection u-100, 10 mL, Use ONLY with Insulins listed on carton, Marketed by: Lilly USA, LLC, Indianapolis, IN 46285. NDC: 0002-0800-01 recalled?

Yes. FDA published recall D-0445-2024 on April 24, 2024. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: HUMALOG.